Terms: = Sarcomas AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Clinical Outcome
4 results:
1. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
Rupp L; Resag A; Potkrajcic V; Warm V; Wehner R; Jöhrens K; Bösmüller H; Eckert F; Schmitz M
Front Immunol; 2023; 14():1185197. PubMed ID: 37261361
[TBL] [Abstract] [Full Text] [Related]
2. One thousand cases of cobalt-based high dose rate brachytherapy treated at a tertiary care center: A retrospective study.
Manur Gururajachar J; Thangaraj R; Thiruraju AP; Agrahara Srinivasa KK; Charith Alva R; Somashekhar Kumar M
Brachytherapy; 2020; 19(4):457-461. PubMed ID: 32331975
[TBL] [Abstract] [Full Text] [Related]
3. Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.
Gui H; Kolster RA; Palmer MB; Brooks JS; Zhang M; Husson MA
Curr Oncol; 2019 Oct; 26(5):e707. PubMed ID: 31708666
[TBL] [Abstract] [Full Text] [Related]
4. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract] [Full Text] [Related]